Who owns Galectin Therapeutics?

Tip: Access positions for across all investors

Analyze quarterly positions in Galectin Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Galectin Therapeutics stock

Who bought or sold Galectin Therapeutics this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 1.9M $3.2M 0% Dec 2023
 View chart
Advisor Group Holdings 1.3M $2.1M -62% Dec 2023
 View chart
Geneos Wealth Management 413k $685k -1% Dec 2023
 View chart
Atria Wealth Solutions 250k $415k -4% Dec 2023
 View chart
Sontag Advisory 184k $305k 0% Dec 2023
 View chart
Cambridge Investment Research Advisors 127k $210k -8% Dec 2023
 View chart
Cutter & CO Brokerage 118k $195k -9% Dec 2023
 View chart
683 Capital Management 111k $184k 100% Dec 2023
 View chart
Commonwealth Equity Services 105k $175k -1% Dec 2023
 View chart
Horizon Kinetics Asset Management 54k $89k -4% Dec 2023
 View chart
D.A. Davidson & Co. 43k $71k 13% Dec 2023
 View chart
Stratos Wealth Partners 41k $97k 0% Mar 2024
 View chart
William Blair $ Company 38k $63k 0% Dec 2023
 View chart
Independent Advisor Alliance 36k $60k 0% Dec 2023
 View chart
Solutions 4 Wealth 36k $60k 100% Dec 2023
 View chart
Traynor Capital Management 35k $83k 0% Mar 2024
 View chart
Jane Street 34k $56k 100% Dec 2023
 View chart
Retirement Guys Formula 34k $81k 57% Mar 2024
 View chart
Millennium Management 28k $46k -73% Dec 2023
 View chart
AE Wealth Management 27k $46k 0% Dec 2023
 View chart
Creative Planning 24k $40k 20% Dec 2023
 View chart
Beacon Capital Management 24k $46k 90% Dec 2023
 View chart
Bank of New York Mellon 23k $38k 0% Dec 2023
 View chart
Summit Trail Advisors 20k $48k 0% Mar 2024
 View chart
Vivaldi Capital Management 19k $33k 0% Dec 2023
 View chart
Wealth Enhancement Advisory Services 19k $45k 0% Mar 2024
 View chart
Charles Schwab Investment Management 17k $29k 0% Dec 2023
 View chart
Wedbush Morgan Securities 16k $26k 0% Dec 2023
 View chart
Citadel Advisors 15k $24k 100% Dec 2023
 View chart
Buckingham Asset Management 13k $22k 0% Dec 2023
 View chart
Dynamic Advisors Solutions 12k $30k 0% Mar 2024
 View chart
Inspire Advisors 11k $19k 100% Dec 2023
 View chart
Mariner Wealth Advisors 11k $18k 0% Dec 2023
 View chart
Citigroup 11k $18k 100% Dec 2023
 View chart
Stock Yards Trust Company 11k $17k 0% Dec 2023
 View chart
Wells Fargo & Company 7.6k $13k -6% Dec 2023
 View chart
Ronald Blue Trust 7.0k $13k 0% Dec 2023
 View chart
Simplex Trading 7.0k $11k -35% Dec 2023
 View chart
Bank of America Corporation 5.6k $9.3k 0% Dec 2023
 View chart
Barrett & Company 3.8k $9.2k 0% Mar 2024
 View chart
Meeder Asset Management 3.8k $6.3k 0% Dec 2023
 View chart
Gradient Investments 3.8k $6.3k 0% Dec 2023
 View chart
Hartland & Co 3.0k $5.0k 0% Dec 2023
 View chart
Sound Income Strategies 3.0k $7.1k 0% Mar 2024
 View chart
IFP Advisors 2.0k $3.3k 0% Dec 2023
 View chart
Jpmorgan Chase & Co 1.8k $3.0k 1860% Dec 2023
 View chart
Benjamin F. Edwards & Company 1.8k $3.0k -68% Dec 2023
 View chart
Royal Bank of Canada 1.1k $2.0k 100% Dec 2023
 View chart
Bradley & Co. Private Wealth Management 1.0k $1.7k 0% Dec 2023
 View chart
UBS Group 622.00 $1.0k 100% Dec 2023
 View chart
Global Retirement Partners 250.00 $455.000000 0% Dec 2023
 View chart
Salem Investment Counselors 167.00 $399.998400 0% Mar 2024
 View chart

Who sold out of Galectin Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Pnc Financial Services Sep 2023 56k $108k
Connor, Clark & Lunn Investment Management Sep 2023 10k $19k
Farther Finance Advisors Sep 2023 350.00 $672.000000